Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-31

Clinical Trial Update: Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma [NA]

View source ↗

Summary

A clinical trial update on quality of life comparing primary transoral robotic surgery (TORS) to IMRT for early-stage oropharyngeal squamous cell carcinoma; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Christian von Buchwald | Conditions: Oropharynx Cancer, Oropharynx Squamous Cell Carcinoma | NA | Status: ACTIVE_NOT_RECRUITING